Rights issue along with positive study results

One possible reason for trading halt rather than just releasing the results which have already been presented to a public forum... to use the huge share price reaction as an opportunity to raise badly needed capital.

The collapse of the Italian deal leave NTI without necessary revenues to get us through to FDA approval without having to cutback on research or marketing. European expansion has been slower than expected. However if these results are as positive as Carrick presenting them would suggest, then this is perfect opportunity to launch a fund raise for another $5m. There would be huge demand as at last we finally have proof that the technology works, and is on track for FDA.

$5m is currently 1/3rd of the market cap, but is also the expected income they have lost from the Italians. This would leave the company looking in a very healthy state post positive news + healthy balance sheet!

Without the capital raise I would expect the stock to double on Wednesday to 33p, therefore it would be roughly a 1 for 6 rights, and stock would trade around 28p post rights. I'll take that thanks.

Just a thought and purely speculation on their options.